Regadenoson Impurities and its Related Products



Displaying 7 results of Regadenoson Impurities

Regadenoson is a pharmaceutical drug used in the diagnosis of heart diseases. Like any other drug, it may contain impurities that can affect its quality and safety. Regadenoson impurities refer to any unwanted substances that may be present in the drug, such as residual solvents, degradation products, or other contaminants. These impurities can impact the drug's efficacy, stability, and safety, and thus need to be monitored and controlled to ensure the drug's quality and safety. The identification, quantification, and control of regadenoson impurities are critical steps in the drug development and manufacturing process.
COMPOUND CATEGORY CAT. No. CAS. No. STOCK STATUS
1-[6-Amino-9-(3,4-dihydroxy-5-hydroxymethyl-tetrahydrofuran-... Impurities CS-O-47370 Not Available Enquire
Regadenoson Impurity 1 Impurities CS-P-08221 1423073-21-5 Enquire
Regadenoson Impurity 2 Impurities CS-P-08222 313348-31-1 Enquire
Regadenoson Impurity 3 Impurities CS-P-08223 313348-29-7 Enquire
Regadenoson Impurity 4 Impurities CS-P-08224 2015222-31-6 Enquire
Regadenoson Impurity 8 Impurities CS-P-08225 Not Available Enquire
Regadenoson Impurity A (Acetate salt) Impurities CS-EO-03817 313348-16-2 (Freebase) Enquire